Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Hay

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
HIV Medicine|January 22, 2015
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)Annemiek de Ruiter, Graham P Taylor, Polly Clayden, et al.
The New England Journal of Medicine|February 8, 2008
HLA-B*5701 screening for hypersensitivity to abacavirSimon Mallal, Elizabeth Phillips, Giampiero Carosi, et al.
AIDS (London, England)|February 22, 2014
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyMargaret T May, Mark Gompels, Valerie Delpech, et al.
AIDS (London, England)|December 17, 2013
Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppressionJemma L O'Connor, Colette J Smith, Fiona C Lampe, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
HIV Medicine|January 22, 2015
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)Annemiek de Ruiter, Graham P Taylor, Polly Clayden, et al.
The New England Journal of Medicine|February 8, 2008
HLA-B*5701 screening for hypersensitivity to abacavirSimon Mallal, Elizabeth Phillips, Giampiero Carosi, et al.
AIDS (London, England)|February 22, 2014
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyMargaret T May, Mark Gompels, Valerie Delpech, et al.
AIDS (London, England)|December 17, 2013
Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppressionJemma L O'Connor, Colette J Smith, Fiona C Lampe, et al.
Pageof 6